» Articles » PMID: 33659029

Trachoma Elimination in Latin America: Prioritization of Municipalities for Surveillance Activities

Overview
Specialty Public Health
Date 2021 Mar 4
PMID 33659029
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To identify and prioritize municipalities in 22 countries of Latin America for trachoma surveillance activities, to measure the absence or prevalence of trachoma, and to support validation and trachoma elimination efforts in the Region of the Americas.

Methods: A prioritization scale was developed in 2017 to rank each municipality by considering a combination of three characteristics: (a) its trachoma vulnerability index, derived from three socioeconomic factors known to be risks for trachoma-lack of access to improved sanitation, to clean drinking water, and to adequate education, according to housing census data from early 2017; (b) its history of trachoma in countries where the disease was not a known public health problem in 2016; and (c) whether or not it shares a border with a municipality where trachoma was a known public health problem in 2016. Municipalities in 22 countries were classified as either very high, high, medium, or low priority for trachoma surveillance. From the Caribbean, only Trinidad and Tobago met inclusion criteria.

Results: The prioritization scale identified 1 053 municipalities in Brazil, Colombia, and Guatemala as priority for trachoma surveillance. In Ecuador, El Salvador, Guyana, Paraguay, Peru, Suriname, and Venezuela, 183 municipalities were ranked as priority, and in Argentina, Belize, Bolivia, Chile, Dominican Republic, Honduras, Nicaragua, Panama, and Uruguay, 677 municipalities were designated a priority for trachoma surveillance.

Conclusions: This prioritization scale will be useful to countries in Latin America that still need to ascertain their current trachoma situation. The absence or prevalence of trachoma in countries designated as very high and high priority for trachoma surveillance activities must be studied to determine the extent of the disease in Latin America.

Citing Articles

Prevalence of trachoma in indigenous and non-indigenous areas, Northeastern Brazil, 2019-2021.

Gomez D, Almeida W, Souza Junior P, Lopes M, Luna E, Zimmermann I Rev Panam Salud Publica. 2024; 48:e19.

PMID: 38464869 PMC: 10924615. DOI: 10.26633/RPSP.2024.19.


Indigenous Eye Health in the Americas: The Burden of Vision Impairment and Ocular Diseases.

Furtado J, Fernandes A, Silva J, Del Pino S, Hommes C Int J Environ Res Public Health. 2023; 20(5).

PMID: 36900846 PMC: 10000964. DOI: 10.3390/ijerph20053820.


Epidemiology and control of trachoma in the state of Ceará, Northeast Brazil, 2007-2021.

Maciel A, Ramos Jr A, Gomes V, Ferreira A, Almeida N, Gomez D Rev Soc Bras Med Trop. 2023; 56.

PMID: 36700599 PMC: 9870276. DOI: 10.1590/0037-8682-0207-2022.


Scientometric analysis of research on trachoma in Brazil, 2000-2020.

Maciel A, Ramos Junior A, Ferreira A, Almeida N, Gomes V, Gomez D Rev Saude Publica. 2022; 56:97.

PMID: 36515309 PMC: 9749654. DOI: 10.11606/s1518-8787.2022056004144.


The elimination of trachoma as a public health problem in Mexico: From national health priority to national success story.

Quesada-Cubo V, Damian-Gonzalez D, Prado-Velasco F, Fernandez-Santos N, Sanchez-Tejeda G, Correa-Morales F PLoS Negl Trop Dis. 2022; 16(8):e0010660.

PMID: 36037211 PMC: 9462675. DOI: 10.1371/journal.pntd.0010660.


References
1.
Barrenechea R, de la Fuente I, Plaza R, Flores N, Segovia L, Villagomez Z . [National survey of blindness and avoidable visual impairment in Argentina, 2013]. Rev Panam Salud Publica. 2015; 37(1):7-12. View

2.
Maco V, Encalada M, Wong C, Marcos L . Historical Aspects of Endemic Trachoma in Peru: 1895-2000. PLoS Negl Trop Dis. 2016; 10(1):e0004116. PMC: 4713155. DOI: 10.1371/journal.pntd.0004116. View

3.
Stocks M, Ogden S, Haddad D, Addiss D, McGuire C, Freeman M . Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis. PLoS Med. 2014; 11(2):e1001605. PMC: 3934994. DOI: 10.1371/journal.pmed.1001605. View

4.
Duerksen R, Limburg H, Lansingh V, Silva J . Review of blindness and visual impairment in Paraguay: changes between 1999 and 2011. Ophthalmic Epidemiol. 2013; 20(5):301-7. DOI: 10.3109/09286586.2013.821497. View

5.
Goodhew E, Priest J, Moss D, Zhong G, Munoz B, Mkocha H . CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl Trop Dis. 2012; 6(11):e1873. PMC: 3486877. DOI: 10.1371/journal.pntd.0001873. View